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n the Pulmonary Vein During Vagal Excitation
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OBJECTIVES The goal of the present prospective study is to evaluate the impact of vagal excitation on
ongoing atrial fibrillation (AF) during pulmonary vein (PV) isolation.
BACKGROUND The role of vagal tone in maintenance of AF is controversial in humans.
METHODS Twenty-five patients (18 with paroxysmal AF, 7 with chronic AF) were selected by
occurrence of vagal excitation during AF (atrioventricular [AV] block: R-R interval 3 s)
produced by PV isolation. Fibrillatory cycle length (CL) in the targeted PV and coronary
sinus (CS) were determined before, during, and after vagal excitation. The CL was available
at PV ostium during vagal excitation in 11 patients.
RESULTS Forty-eight episodes of vagal excitation were observed. During vagal excitation, CL abruptly
decreased both in CS and PV (CS, 164  20 ms to 155  23 ms, p  0.0001; PV, 160 
22 ms to 143 28 ms, p 0.0001), and both returned to the baseline value with resumption
of AV conduction. The decrease in PVCL occurred earlier (2.5  1.5 s vs. 4.0  2.6 s, p 
0.01) and was of greater magnitude than that in CSCL (16 16 ms vs. 8 9 ms, p 0.01).
A sequential gradient of CL was observed from PV to PV ostium and CS during vagal
excitation (138  29 ms, 149  24 ms, and 159  26 ms, respectively). The decrease in CL
was significantly greater in paroxysmal than in chronic AF (CS, 11  9 ms vs. 5  7 ms,
p  0.05; PV, 23  25 ms vs. 8  14 ms, p  0.05).
CONCLUSIONS Vagal excitation is associated with shortening of fibrillatory CL. This occurs earlier in PV
with a sequential gradient to PV ostium and CS, suggesting that vagal excitation enhances a
driving role of PV. (J Am Coll Cardiol 2006;47:774–80) © 2006 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.043of Cardiology Foundation
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che role of autonomic tone in the onset, maintenance, and
ermination of atrial fibrillation (AF) has been suggested in
umans (1–6). In an animal model, vagal nerve stimulation
ecreases refractoriness and facilitates the induction and
aintenance of AF (7,8), and this effect is prevented by
blation of the atrial parasympathetic nerve system (9,10).
owever, the mechanism of vagal excitation contributing to
he maintenance of AF has not been clear in humans.
The goal of the present study is to investigate changes in
F cycle length (CL) during vagal excitation produced by
adiofrequency (RF) energy delivery for pulmonary vein (PV)
isconnection in patients with paroxysmal and chronic AF.
ETHODS
atient population. Among 314 consecutive patients (213
ith paroxysmal AF, 101 with persistent or chronic AF) who
nderwent AF ablation in our institution, PV isolation was
erformed during ongoing AF in 272 patients (171 with
aroxysmal AF, 101 with persistent or chronic AF). Twenty-
ve patients (9.2%; 18 with paroxysmal AF, 7 with chronic
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ccepted October 10, 2005.F) were selected based on the occurrence of atrioventric-
lar (AV) block with an R-R interval 3 s during AF
roduced by RF energy application for PV isolation. The
ccurrence of vagal excitation during sinus rhythm (sinus
radycardia or hypotension) was not included in the
resent study. The mean age was 55  9 years, two
omen were included, and AF duration was 88  72
onths. All patients had no structural heart disease except
or one with aortic valve replacement. No patient was
iagnosed with vagotonic AF.
Twenty-five patients, matched for age, gender, structural
eart disease, classification of AF, and duration of AF, were
elected as control patients for clinical outcome (Table 1).
atheter ablation. Anti-arrhythmic drugs were discontin-
ed 5 half-lives before ablation except for amiodarone,
hich was taken by six patients (24%) at the time of the
rocedure. All patients had effective anticoagulation for 1
onth and transesophageal echocardiography before abla-
ion. A written informed consent was obtained from all
atients.
A 6-F quadripolar catheter (Xtrem, Ela Medical, Mon-
rouge, France) was positioned in the coronary sinus (CS).
10-pole circumferential catheter (Lasso, Biosense-
ebster, Diamond Bar, California) for PV ostial mapping
nd a 4-mm irrigated-tip ablation catheter (Biosense-
ebster) were used. Surface electrocardiogram and intra-
ardiac electrograms were filtered from 30 to 500 Hz and
easured at a paper speed of 100 mm/s with a digital
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February 21, 2006:774–80 Impact of Vagal Excitation on AF Cycle Lengthmplifier/recording system (Bard Electrophysiology,
owell, Massachusetts). A single bolus dose of 50 IU/kg of
eparin was administered after the transseptal puncture and
epeated only for procedures lasting more than four hours.
The RF application was performed at 1 cm proximal to
he ostium of all PVs with a power limit of 30 W. When RF
as applied at the anterior and inferior rim of the left PVs,
elivered power was limited as 25 W. If ipsilateral PVs were
ocated closely, these two PVs were isolated en bloc.
blation catheter was dragged every 30 to 60 s during
ontinuous RF delivery. The end point was a disappearance
r dissociation of the PV potentials on a circumferential
atheter. When a vagal response with an R-R interval  5 s
as observed, RF delivery was discontinued.
tudy protocol. The mean CL in the CS (CSCL) and the
argeted PV (PVCL) were determined at the following
imes: 1) before the commencement of RF application
baseline), 2) 5 s before, 3) during, and 4) 5 s after the
pisode of vagal excitation. The CSCL was selected because
f the stability of catheter allowing reproducible serial
easurement. In addition, CL was available at the PV
stium in 11 patients during vagal excitation. The mean CL
Table 1. Baseline Characteristics of the Patien
Characteristics
Age (yrs)
Gender (female, %)
AF type (paroxysmal/chronic)
AF duration (months)
Persistent duration (range: months)
LA diameter
Parasternal (mm)
Longitudinal (mm)
Transversal (mm)
LV ejection fraction (%)
Structural heart disease A
Procedure and outcome
PV isolation (%)
Substrate modification (%)
Repeated procedure
Anti-arrhythmics after the procedure (%)
Overall success (%)
Length of follow-up since the last
procedure (months)
Abbreviations and Acronyms
AF  atrial fibrillation
AV  atrioventricular
CL  cycle length
CS  coronary sinus
CSCL  cycle length in the coronary sinus
PV  pulmonary vein
PVCL  cycle length in the pulmonary vein
RF  radiofrequencyAF  atrial fibrillation; LA  left atrial; LV  left ventricular; Pas defined as an average of 30 consecutive cycles. They
ere measured with a dedicated system (Bard Electrophys-
ology), and the detection of potentials was manually
hecked with online calipers at a paper speed of 100 mm/s.
f an R-R interval during vagal excitation was shorter than
total duration of 30 consecutive cycles, CSCL and PVCL
ere determined by averaging all cycles during the episode
f vagal excitation. A continuous or fragmented activity or a
otential interval  50 ms was counted as a single activity. A
ecrease in PVCL or CSCL of  10 ms during vagal
xcitation was considered as a significant decrease. The timing
f onset of a significant decrease in PVCL and CSCL was
easured from the last QRS before vagal excitation.
tatistical analysis. All variables are reported as mean 
D. Comparison between groups was performed with the
tudent t test. Sequential data measurements were analyzed
y repeated-measures analysis of variance followed by the
ukey post hoc test for multiple comparisons. Categorical
ariables were compared with the Fisher exact test. p 0.05
as considered to indicate statistical significance.
ESULTS
orty-eight episodes of vagal excitation were observed, and
he R-R interval during these episodes was 8.7  4.1 s
range, 3.0 to 19.6 s). The targeted PV was the left superior
V in 19, the left inferior PV in 7, the right superior PV in
, and the right inferior PV in 1 patient.
The RF site producing vagal excitation was observed at a
iscrete location at approximately 1 cm proximal to the
stium of each vein: the anterosuperior ostium of the left
uperior PV, the inferior ostium of the left inferior PV, the
d Procedural Outcomes
y Group
 25)
Control Group
(n  25)
p
Value
5  9 56  8 NS
(8%) 2 (8%) NS
18/7 18/7 NS
8  72 90  66 NS
2–24 5–24 NS
1  9 44  7 NS
4  9 54  9 NS
2  8 41  9 NS
9  10 66  13 NS
valve
acement (1)
Aortic valve
replacement (1)
–
(100%) 25 (100%) NS
(60%) 15 (60%) NS
(20%) 9 (36%) NS
(28%) 5 (20%) NS
(80%) 20 (80%) NS
 5.5 7.7  4.0 NSts an
Stud
(n
5
2
8
1
4
5
4
6
ortic
repl
25
15
5
7
20
6.2V  pulmonary vein.
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Impact of Vagal Excitation on AF Cycle Length February 21, 2006:774–80nterior (septal) ostium of the right superior PV, and the
nterior (septal) ostium of the right inferior PV.
L in the CS and PV. The CSCL and PVCL before RF
elivery producing vagal excitation were 166  21 ms and
56  23 ms, respectively (p  0.03). Changes in CL
uring vagal excitation were analyzed in 39 episodes because
V potentials had disappeared in 9 episodes when vagal
xcitation was observed.
There was no change in CSCL and PVCL from baseline
o 5 s before vagal excitation (CSCL, 165  22 ms to 164
20 ms, p  NS; PVCL, 158  23 ms to 160  22 ms,
NS) (Fig. 1). The CSCL and PVCL decreased abruptly
uring vagal excitation to 155  23 ms and 143  28 ms (p
0.0001, p  0.0001, respectively; vs. 5 s before vagal
xcitation), and the magnitude of decline was significantly
reater in PVCL than in CSCL (16  16 ms vs. 8  9 ms,
 0.01) (Fig. 1). The PVCL was shorter than the CSCL
uring vagal excitation in 31 episodes (79%). In 13 episodes,
he mean CL at the PV ostium was measured during vagal
xcitation (PV ostium CL). There was a sequential gradient
f CL between the PV, PV ostium, and CS during vagal
xcitation (PVCL, 138  29 ms; PV ostium CL, 149  24
s; CSCL, 159  26 ms) (Fig. 2).
The CL was maintained at the decreased value until
iscontinuation of RF application (Fig. 3). In one episode,
hortening of PVCL persisted1 min after discontinuation
f RF application, whereas CSCL returned to the value
efore vagal excitation simultaneous to the resumption of
V conduction in all of the other episodes. A significant
ecrease in PVCL and CSCL (gradient 10 ms) was
bserved in 23 (59%) and 20 (51%) of 39 episodes, respec-
ively. In these episodes, the significant decrease in PVCL
ppeared earlier than that in CSCL by 1.6  1.6 s (2.5 
.5 s vs. 4.0  2.6 s after the last QRS, p  0.01).
Five seconds after vagal excitation, the CSCL had re-
igure 1. An overall change in cycle length in the coronary sinus (CSCL)
nd pulmonary vein (PVCL). *p  0.0001, CSCL during vagal excitation
ersus before ablation, before vagal excitation, and after vagal excitation.
p  0.002, PVCL during vagal excitation versus before ablation. ‡p 
.0001, PVCL during vagal excitation versus before vagal excitation. §p 
.05, PVCL before vagal excitation versus after vagal excitation, p 
.0001, PVCL during vagal excitation versus during vagal excitation.urned to the value before vagal excitation (163  20 ms,
F
( NS, vs. before AV block) (Fig. 1), whereas the PVCL
s after vagal excitation was significantly shorter than that
efore vagal excitation (156  25 ms, p  0.05, vs. before
agal excitation) (Fig. 1).
Changes in CSCL and PVCL were observed both in
atients with paroxysmal AF and in patients with chronic
F (Figs. 4 and 5). However, the decreases in CSCL and
VCL were significantly greater in patients with paroxys-
al AF than chronic AF (CSCL, 11  9 ms vs. 5  7 ms,
 0.05; PVCL, 23  25 ms vs. 8  14 ms, p  0.05).
Radiofrequency was applied repeatedly at the site where
agal excitation had been produced. In all patients except
ne, an additional one to three RF applications abolished
agal excitation. Vagal excitation was still reproduced in one
atient despite six RF applications.
blation outcomes. In patients with paroxysmal AF, AF
erminated during PV isolation in 15 of 18 patients (83%) in
he study group, and in 15 of 18 patients (83%; p  NS) in
he control group, respectively. In patients with chronic AF,
F did not terminate in both groups during PV isolation.
he PV isolation was performed in all patients, and addi-
ional substrate modification was performed in 15 patients
n both groups, respectively (Table 1).
The study and control group were followed for 6.2  5.5
onths and 7.7  4.0 months since the last procedure,
espectively (pNS). There was no significant difference in
he number of patients who required antiarrhythmic after
he last procedure and the arrhythmia-free rate between the
wo groups. The incidence of the repeated procedure was
ower in the study group without statistical significance
Table 1).
ISCUSSION
ajor findings. Major findings in the present study are as
ollows. 1) The PVCL and CSCL decreased during vagaligure 2. Cycle length during vagal excitation in the pulmonary vein
PVCL), pulmonary vein ostium (PVos CL), and coronary sinus (CSCL).
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February 21, 2006:774–80 Impact of Vagal Excitation on AF Cycle Lengthxcitation produced during RF applications at the PV ostia.
he change in PVCL occurred earlier and persisted longer,
nd the decline was greater than that in CSCL. 2) The
cceleration of the fibrillatory CL was significantly greater
n patients with paroxysmal AF than in those with chronic
F. 3) There was no difference in the long-term clinical
utcome between the study group and a control group.
agal tone and fibrillatory CL. Acetylcholine and vagal
erve stimulation have been used in animal AF models to
nduce AF (7,8,11), and vagal denervation prevents the
nduction of AF, confirming the role of vagal tone in these
nimal models (9,10). Enhanced vagal tone shortens action
otential duration and atrial refractoriness, which may
horten the wavelength and fibrillatory CL. It has been
onsidered, therefore, that a greater number of wavelets can
oexist and AF is more likely to be sustained during vagal
igure 3. (A) Electrograms during vagal excitation produced by radiofr
aroxysmal atrial fibrillation. The last QRS is followed by a sudden decrease
ctivity. (B) Cycle length in the coronary sinus (CS) and PV during the sam
AV) block was 151 ms, and decreased to 85 ms during AV block. Meanxcitation. iThe effect of vagal tone on the fibrillatory CL is not only
ddressed by multiple wavelets theory. Stable micro–
e-entrant sources (rotor) have been observed during AF in
he presence of acetylcholine in Langendorff-perfused sheep
earts (12), and this is hypothesized to be the mechanism of
F. A rotor accelerates and is stabilized in the presence of
high concentration of acetylcholine (13,14). Thus, rotor
an also cause acceleration of fibrillatory CL by enhanced
agal tone. Furthermore, vagal stimulation combined with
ympathetic stimulation has been shown to induce triggered
ctivity in the PV (15).
he heterogenous effect of vagal tone. The heteroge-
eous atrial electrophysiological property is an important
actor contributing to the maintenance of AF (16,17).
cetylcholine released from nerve terminals has the effect in
he millimeter-sized localized region (18). Thus, autonomic
cy energy delivery for pulmonary vein (PV) isolation in a patient with
cle length in the pulmonary vein. Blue and red arrows highlight the atrial
sode displayed in (A). Mean cycle length in the PV before atrioventricular
length in the CS does not change significantly in this episode (150 ms).equen
in cy
e epinnervation is hypothesized to contribute to the heteroge-
n
c
h
s
p
t
o
A
p
a
(
p
o
i
F
C he sa
1 le len
778 Takahashi et al. JACC Vol. 47, No. 4, 2006
Impact of Vagal Excitation on AF Cycle Length February 21, 2006:774–80eous electrophysiological property in atria, and this may be
ritical for perpetuation of AF. Olgin et al. (19) showed that
eterogenous sympathetic denervation in the atrium is
ufficient to produce sustained AF in an animal model. The
resent study shows a dispersion of accelerated CL between
he PV and CS, which suggests heterogeneous distribution
f vagal nerve terminals in patients with AF.
igure 4. (A) Electrograms during vagal excitation in a patient with chron
ycle length in the coronary sinus (CS) and pulmonary vein (PV) during t
56 ms to 144 ms during atrioventricular block. Note that changes in cycFigure 5. A change in cycle length in the CS (CSCL, A) and PV (PVCrrhythmogenesis of the PV. The role of the PV in
ersisting AF was shown by prolongation of fibrillatory CL
nd non-inducibility of AF after disconnection of the PV
20). Arrhythmogenicity of the PV may be associated with
articular electrophysiological and histologic characteristics
f this region (21,22). Vulnerability of the PV to an
ncreased vagal tone was shown in the present study, and
ial fibrillation (AF). Blue and red arrows highlight the atrial activity. (B)
me episode displayed in (A). Mean cycle length in the PV decreased from
gth are smaller than in a patient with paroxysmal AF (Fig. 3).ic atrL, B) in patients with paroxysmal and chronic atrial fibrillation.
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ogenicity of the PV.
During vagal excitation, the PVCL is shorter than the
SCL, and the shortening of the PVCL occurred earlier
nd persisted longer than that in the CSCL. This suggests
hat increased vagal tone has direct effects on PVCL and the
cceleration of the CSCL is secondary to that of the PVCL
Fig. 6). This is supported by a sequential gradient of CL to
he PV ostium, and then to the CS. This suggests that
igh-frequency PV activity drives the rest of the atrium
23). Results of the present study indicated that PVs are
mportant effectors of vagal excitation. Therefore, PV iso-
ation may attenuate the arrhythmogenic effect of vagal tone
n addition to elimination of triggering beats. This may be
n additional mechanism that prevents clinical recurrence of
F (Fig. 6).
A decrease in CL during vagal excitation was greater in
he PV than in the CS in both paroxysmal and chronic AF,
ndicating that the PV is vulnerable to vagal tone in both
ohorts. However, a lesser change in CL during vagal
xcitation was shown in chronic AF. This suggests a lesser
ontribution of autonomic tone to arrhythmogenesis in
hronic AF, which may be associated with the limited
fficacy in PV isolation for chronic AF (24,25).
The mechanism of vagal excitation during RF application
t the PV is hypothesized as thermal injury of vagal afferent
eceptors (26). Histologic study shows that nerve terminals
ith acetylcholinesterase activity are distributed widely in
he left atrium roof, ostia of the PVs, and lateral RA (27),
hereas RF application produces vagal excitation at discrete
ites in clinical studies. Recently, it has been reported that
bolition of vagal excitation by RF application is associated
ith better long-term outcome in AF catheter ablation (28).
his was not confirmed in the present study; however, the
resent study was performed using a different methodology
nd end point without identifying vagal terminals or auto-
omic ganglia. Nakagawa et al. (29) reported that high-
requency pacing is feasible for identifying autonomic ganglia,
nd catheter ablation targeting the ganglia may effectively
igure 6. The hypothesized fibrillatory process during vagal excitation and
xcitation, PVs act as driving sources. Acceleration of cycle length in the PV
aintenance of atrial fibrillation. (B) After PV isolation, acceleration of aenervate the atrium. They achieved a better clinical outcomey catheter ablation targeting autonomic ganglia in addition to
V isolation in paroxysmal and persistent AF. However, the
resent study suggests that vagal denervation may have a
esser impact in chronic than in paroxysmal AF.
tudy limitations. Vagal excitation in the present study
as observed dominantly during ablation at the left-sided
Vs, and its incidence was even lower than in the previous
eport (28) because we excluded sinus bradycardia and sinus
rrest from the definition of vagal excitation, which is more
ommonly observed during ablation at the right-sided PVs.
n increase in the R-R interval produced by RF application
ay be caused also by a decrease in sympathetic tone, which
as not evaluated in the present study.
Although the present study indicates that vagal excitation
ontributes to arrhythmogenesis of AF, further studies are
equired to investigate the role of vagal tone in initiation and
aintenance of AF in the clinical setting.
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